TRML
Tourmaline Bio
TRML
TRML
Delisted
TRML was delisted on the 27th of October, 2025.
134 hedge funds and large institutions have $1.03B invested in Tourmaline Bio in 2025 Q3 according to their latest regulatory filings, with 52 funds opening new positions, 22 increasing their positions, 44 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
9.53% less ownership
Funds ownership: 93.68% → 84.15% (-9.5%)
50% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 44
59% less call options, than puts
Call options by funds: $1.63M | Put options by funds: $3.97M
Holders
134
Holding in Top 10
9
Calls
$1.63M
Puts
$3.97M
Top Buyers
| 1 | +$49.2M | |
| 2 | +$46.2M | |
| 3 | +$33.3M | |
| 4 |
TAL
TIG Advisors LLC
New York
|
+$29.6M |
| 5 |
AllianceBernstein
Nashville,
Tennessee
|
+$24.6M |
Top Sellers
| 1 | -$40.6M | |
| 2 | -$27.4M | |
| 3 | -$18.6M | |
| 4 |
BOCH
Blue Owl Capital Holdings
New York
|
-$15.9M |
| 5 |
OCA
Octagon Capital Advisors
New York
|
-$14.5M |
